SEC Form 4 · accession 0001638599-15-000269
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael M Goldberg
Director
Period of report
Oct 8, 2015
Accepted (ET)
Oct 20, 2015 · 12:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 8, 2015 | A | 13,247 | $2.26 | A | 331,572 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired from the Issuer in lieu of cash compensation for board service during 2Q and 3Q 2015.